Current calls, week 2, 2018

Published 2018-01-08 17:28. Updated 2018-01-10 13:59

Tips from KI Grants Office about current calls

Svenska och nordiska anslag

Research Project – Swedish Research Council for Health, Working Life and Welfare (FORTE)

These aim at promoting research within Forte’s overall responsibilities of health, working life and welfare. Grants for research projects within the annual open call for proposals are awarded for a maximum of 3 years, to researchers with a PhD. A maximum of SEK 5 million can be granted for a three-year project. For a two-year project, you can apply for a maximum of SEK 3 million.

Closing date: 1 Feb 2018

Research Project – Swedish Research Council for Health, Working Life and Welfare (FORTE) 

Postdoc grant– Swedish Research Council for Health, Working Life and Welfare (FORTE)

The open annual call for proposals for postdoc grants 2018 is now open for applications. They welcome all applications within Forte’s overall responsibilities of health, working life and welfare. The grant is awarded for 2 years and corresponds to a full-time salary.

Closing date: 1 Feb 2018

Postdoc grant– Swedish Research Council for Health, Working Life and Welfare (FORTE) 

Junior research grant – Swedish Research Council for Health, Working Life and Welfare (FORTE)

The aim of the grant is to support early stage researchers who work within health, working life and welfare. Junior researcher grants are awarded for four years and can be granted up to six years after PhD examination. You can apply for a maximum of SEK 5 million for the first three years in total. For the fourth year, there is a fixed amount of SEK 800 000 for career development support

Closing date: 1 Feb 2018

Junior research grant – Swedish Research Council for Health, Working Life and Welfare (FORTE)

ALF-projektmedel medicin - Stockholms läns landsting

Dessa stöder kliniskt inriktade medicinska forskningsprojekt. Den totala budgeten uppgår till SEK 74 miljoner. Bidrag uppgår till SEK 1m per år, under högst tre år.

Closing date: 19 Feb 2018

ALF-projektmedel medicin - Stockholms läns landsting 

To prevent sick leave and promote return to work 2018– Swedish Research Council for Health, Working Life and Welfare (FORTE)

This is a call for proposals for research on interventions to prevent sick leave or promote the return to work after sick leave. The focus for the research is individuals with mental illness and pain. The total budget is SEK 40 million over a period of three years.  

Closing date: 21 Feb 2018

To prevent sick leave and promote return to work 2018– Swedish Research Council for Health, Working Life and Welfare (FORTE) 

Nationell individrörlighet för innovation – Vinnova

Dessa ger forskare möjlighet att under en 18 månadsperiod tillbringa tre månader vid en samarbetsorganisation i annan sektor, i syfte att nå ny eller förnyad samverkan mellan nationella eller internationella organisationer. Bidrag uppgår till SEK 300,000 var, och stöder upp till 50 procent av de stödberättigande kostnaderna. 

Closing date: 27 Feb 2018

Nationell individrörlighet för innovation – Vinnova 

Research project – The Kavli Trust Programme on Health Research

The Kavli Trust Programme on Health Research is committed to fund research on preventing and combating serious illness and on alleviating humanitarian need. In 2017, 2018 and 2019 the programme will be devoted to the funding collaborative research projects addressing selected evidence gaps in children and adolescents mental health.

Closing date: 27 Feb 2018

Research project – The Kavli Trust Programme on Health Research 

Forskningsstipendier och projektanslag – Ögonfonden

Ögonfonden inbjuder ansökningar om. Dessa stöder vetenskaplig ögon- och synforskning i syfte att förebygga och behandla ögonsjukdomar samt att effektivt utnyttja kvarvarande synförmåga. Behöriga att söka är ögonforskare inom svenska lärosäten och svenska universitet. Forskningsstipendier värda SEK 25,000 var är tillgängliga, samt projektanslag värda mellan SEK 50,000 och SEK 250,000 var.

Closing date: 28 Feb 2018

Forskningsstipendier och projektanslag – Ögonfonden 

Europeiska anslag

Joint research call -- ERA-Net GENDER-NET Plus, EU and other funders

This supports interdisciplinary research exploring the gender dimension in research topics relating to one or more of the following sustainable development goals: good health and well-being; infrastructure, industrialisation and innovation; and climate action. Applications must include at least three partners from three different participating countries. Funding is worth up to €1 million per project over up to three years.

Closing date: Consortium’s pre-proposal submission to GENDER-NET Plus: 01 March 2018 17:00 CET; Swedish PI’s pre-proposal submission to Vetenskapsrådet: 06 March 2018 14:00. Full proposals due mid July 2018

Joint research call -- ERA-Net GENDER-NET Plus, EU and other funders 

Joint research call -- ERA-Net GENDER-NET Plus, EU and other funders  (Vetenskapsrådet)

Research grants -- European Foundation for Alcohol Research, EUR

These support research on any aspect of biomedical or psychosocial research into beer or alcohol. Applicants should be from established European research institutions or universities. Those from countries outside the EU may apply for research undertaken in partnership with a member of the EU. Researchers who have received funding from the foundation will not be eligible for another grant for three years after the date of the successful application.

Grants are worth up to €50,000 per year for a maximum period of two years.

Closing date:  Pre-proposals due on 5 March 2018. Full proposals due on 7 May 2018.

Research grants -- European Foundation for Alcohol Research, EUR 

Research unit -- European Society for Paediatric Endocrinology, EUR

The ESPE Research Unit is a collaborative research grant that supports research in paediatric endocrinology for both physicians and scientists. Members of ESPE actively involved in paediatric endocrinology may apply. Non-ESPE members may participate as co-investigators. Applications must have a designated principal investigator and at least two additional applicants from other European and Mediterranean countries. One large grant and one small grant are available annually. The large grant is worth €130,000 for a period of two years and the smaller grant is worth €15,000 for a period of one year.

Closing date: Preliminary applications due by 26 February 2018; full applications due by 16 April 2017. This call is repeated once a year.

Research unit -- European Society for Paediatric Endocrinology, EUR 

Romain Pauwels research award -- European Respiratory Society (ERS), EUR

Through the support of GlaxoSmithKline, the ERS offers an Award of €50,000 to encourage a new generation of lung scientists and to support young researchers in their quest to understand and treat respiratory illnesses. The grant will be awarded for excellence in previous achievements in clinical research on airway diseases.

Candidates may be from anywhere in the world, and must be society members who are 45 years of age or under at the time of the application deadline. Candidates may not have received the award previously, or any other ERS award or grant in the last three years.

Closing date: 28 Feb 2018

Romain Pauwels research award -- European Respiratory Society (ERS), EUR

EUREKA bursary - European League Against Rheumatism, EUR

This supports young rheumatologists to participate in the EUREKA Institute for Translational Medicine Program. Applicants should be rheumatologists, under the age of 40 and have an interest in translational medicine.

Two bursaries, worth €2,500 each, are available to cover the programme costs.

Closing date: 28 Feb 2018

EUREKA bursary - European League Against Rheumatism, EUR 

Research grants -- ME Research UK, GB

These fund novel clinical and biomedical studies that help unravel the biology of myalgic encephalomyelitis or chronic fatigue syndrome, and studies that may point towards therapeutic strategies. Applications for pilot studies and seed-corn projects, including those that seek support for consumables rather than staff costs, are particularly welcomed.

Closing date: none

Research grants -- ME Research UK, GB 

Amerikanska anslag

Federal Funding agencies

Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01): NIH

The goal of this Funding Opportunity Announcement is to support research that will define and validate a set(s) of molecular biomarkers and/or bio-signatures indicating the degree of loss of functional reserve, or of resilience of the host defense mechanisms, at different phases of HIV-1 pathogenesis in individuals with substance use disorders (SUDs).  

Closing date: April 17, 2018, by 5:00 PM local time of applicant organization.

Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01): NIH, Funding Opportunity Announcement (FOA): RFA-DA-18-023

Transformative Technology Development for the Human BioMolecular Atlas Program (UG3): NIH

The purpose of this Funding Opportunity Announcement (FOA) is to solicit transformative technologies that will significantly expand throughput, multiplexing and discrimination of biomolecules in human tissues for comprehensive mapping of individual cells and their context in human tissues. This FOA supports the accelerated proof-of-principle demonstration and validation of promising tools, techniques and systems that can be integrated, scaled and applied to multiple human tissues. Funded projects will be expected to work closely as part of the Human BioMolecular Atlas Program to catalyze development of a framework for mapping the human body with high resolution.

Closing date: March 2, 2018, by 5:00 PM local time of applicant organization.

Transformative Technology Development for the Human BioMolecular Atlas Program (UG3): NIH Funding Opportunity Announcement (FOA): RFA-RM-17-025

Early-life Factors and Cancer Development Later in Life (R01): NIH

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. Ultimately, a better mechanistic understanding of how early-life events and exposures contribute to the etiology of cancer later in life will allow for the development of effective interventions during pregnancy or early life that may have a profound impact on cancer prevention.

Closing date: standard dates apply, by 5pm local time of applicant organization until January 8, 2021.

Early-life Factors and Cancer Development Later in Life (R01): NI, Funding Opportunity Announcement (FOA): PA-18-529 (R01)PA-18-531 (R03)PA-18-532 (R21).

Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimer’s Disease (R01): NIH

This FOA invites applications on descriptive, basic and translational studies of APOE2 to delineate the functional effects of ApoE2 on healthy aging of the brain and other tissues. The primary focus is on the “ApoE2-Aging-AD" relationship and the mechanistic effects of the protective variant on aging and potential interaction/crosstalk between tissues in the aging process and AD. These studies are expected to generate new mechanistic insights that involve brain and/or other organs and assist in the identification of potential prognostic and diagnostic markers and therapeutic targets for AD and other age-related cognitive disorders. Eventually, the findings from these studies could lead to translational research opportunities not only to prevent or delay the onset of AD, but also to protect against multiple age-related conditions.

Closing date: March 28, 2018, by 5:00 PM local time of applicant organization.

Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimer’s Disease (R01): NIH, Funding Opportunity Announcement (FOA): RFA-AG-18-022 (R01)

Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01): NIH

This Funding Opportunity Announcement (FOA) invites innovative research focused on understanding the consequences of amyloid protein polymorphism in regulation and initiation of early pathogenesis in Alzheimer's disease (AD). Specifically, this FOA encourages collaborative approaches designed to identify and characterize the regulation of biochemical and cellular pathways that are responsible for the differential accumulation of various protein conformers in AD clinical subtypes.

Closing date: March 28, 2018, by 5:00 PM local time of applicant organization.

Consequences of amyloid protein polymorphisms in Alzheimer's disease (R01): NIH, Funding Opportunity Announcement (FOA): RFA-AG-18-025 (R01)

Foundations
Strategic Research Agreements: JDRF

JDRF’s Strategic Research Agreements provide research funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research. The Strategic Research Agreement is a partnership between Investigator(s) and JDRF Scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation.

Closing date: Feb 1, 2018, by 5:00 PM EST.

 Strategic Research Agreements: JDRF

Target Identification in Lupus Program (TIL) & Novel research grant (NRG) program: Lupus Research Alliance

Target Identification in Lupus Program (TIL) grants are intended to be highly focused on lupus and, as such, should lead directly to knowledge that will facilitate drug discovery and/or testing of new treatments. Novel Research Grants (NRG) are intended to support projects that evidence high promise for advancing the understanding of Systemic Lupus Erythematosus. Novel Research Grants provide early stage support for exceptionally creative and innovative approaches to major challenges in lupus research.

Closing date: Feb 9, 2018, by 5:00 PM EST.

Target Identification in Lupus Program (TIL) & Novel research grant (NRG) program: Lupus Research Alliance

2018 Research Funding: North American Spine Society (NASS)

Research Grants

Research grants should focus on basic science, clinical or translational research. Basic research may focus on projects that further our understanding of the mechanisms of disease and developing novel models for prevention and/or treatment. Clinical research may focus on projects that investigate the

epidemiology, prevention, and or treatment of spine disease. Translational research may focus on projects that move findings from the ‘bench to bedside.

Young Investigator Grants

One to two Young Investigator Grants may be awarded each year.

Nontraditional, Nonsurgical Treatment Grants

This grant supports research of disc-related and/or neuropathic back pain by nonsurgical techniques. These funds must be used for new, nontraditional methods of nonsurgical treatment of such back and neck pain and radiculopathy.

Clinical Traveling Fellowship

The Clinical Traveling Fellowship spans at least one month to be spent in three to five different medical centers studying spine techniques.

Research Traveling Fellowship

The Research Traveling Fellowship spans at least five months at one medical center (other than the facility at which the applicant currently practices).

Closing dates: Feb 12, 2018, by 11:59 PM CST (Letter of Intent); May 14, 2018 by 11:59 PM CDT (Full proposal and by invitation only).

2018 Research Funding: North American Spine Society (NASS) 

First/Second Year Clinical Fellowship Awards: Cystic Fibrosis Foundation (CFF)

CFF invites applications for the First Year and/or Second Year Clinical Fellowship award from physicians interested in chronic pulmonary and gastrointestinal diseases of children, adolescents, and adults with CF. The intent of this program is to encourage specialized training in the early career development stage and to prepare well-qualified candidates for careers related to CF.

Closing date: Feb 15, 2018, by 5:00 PM EST.

First/Second Year Clinical Fellowship Awards: Cystic Fibrosis Foundation (CFF) 

Links